This seems counterintuitive given CLDN1’s pro-tumor role described elsewhere; it suggests a subset of CRCs undergo claudin switching where CLDN1 is lost in very advanced tumors, possibly due to EMT. This evidence concerns the gene CLDN1 and neoplasm.